@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form> a fhir:CodeSystem ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "bd-dose-form"] ; # 
  fhir:text [
     fhir:status [ fhir:v "generated" ] ;
     fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><div xml:lang=\"en\" lang=\"en\"><hr/><p><b>English</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem bd-dose-form</b></p><a name=\"bd-dose-form\"> </a><a name=\"hcbd-dose-form\"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">TAB<a name=\"bd-dose-form-TAB\"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style=\"white-space:nowrap\">DTAB<a name=\"bd-dose-form-DTAB\"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style=\"white-space:nowrap\">CAP<a name=\"bd-dose-form-CAP\"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style=\"white-space:nowrap\">SYP<a name=\"bd-dose-form-SYP\"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style=\"white-space:nowrap\">SUSP<a name=\"bd-dose-form-SUSP\"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style=\"white-space:nowrap\">PFS<a name=\"bd-dose-form-PFS\"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style=\"white-space:nowrap\">INJ<a name=\"bd-dose-form-INJ\"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style=\"white-space:nowrap\">SOL<a name=\"bd-dose-form-SOL\"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style=\"white-space:nowrap\">CRM<a name=\"bd-dose-form-CRM\"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style=\"white-space:nowrap\">LOT<a name=\"bd-dose-form-LOT\"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div><div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem bd-dose-form</b></p><a name=\"de-bd-dose-form\"> </a><a name=\"de-hcbd-dose-form\"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">TAB<a name=\"de-bd-dose-form-TAB\"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style=\"white-space:nowrap\">DTAB<a name=\"de-bd-dose-form-DTAB\"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style=\"white-space:nowrap\">CAP<a name=\"de-bd-dose-form-CAP\"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style=\"white-space:nowrap\">SYP<a name=\"de-bd-dose-form-SYP\"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style=\"white-space:nowrap\">SUSP<a name=\"de-bd-dose-form-SUSP\"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style=\"white-space:nowrap\">PFS<a name=\"de-bd-dose-form-PFS\"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style=\"white-space:nowrap\">INJ<a name=\"de-bd-dose-form-INJ\"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style=\"white-space:nowrap\">SOL<a name=\"de-bd-dose-form-SOL\"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style=\"white-space:nowrap\">CRM<a name=\"de-bd-dose-form-CRM\"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style=\"white-space:nowrap\">LOT<a name=\"de-bd-dose-form-LOT\"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div><div xml:lang=\"fr\" lang=\"fr\"><hr/><p><b>French</b></p><hr/><p class=\"res-header-id\"><b>Narratif généré : CodeSystem bd-dose-form</b></p><a name=\"fr-bd-dose-form\"> </a><a name=\"fr-hcbd-dose-form\"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Affichage</b></td><td><b>Définition</b></td></tr><tr><td style=\"white-space:nowrap\">TAB<a name=\"fr-bd-dose-form-TAB\"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style=\"white-space:nowrap\">DTAB<a name=\"fr-bd-dose-form-DTAB\"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style=\"white-space:nowrap\">CAP<a name=\"fr-bd-dose-form-CAP\"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style=\"white-space:nowrap\">SYP<a name=\"fr-bd-dose-form-SYP\"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style=\"white-space:nowrap\">SUSP<a name=\"fr-bd-dose-form-SUSP\"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style=\"white-space:nowrap\">PFS<a name=\"fr-bd-dose-form-PFS\"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style=\"white-space:nowrap\">INJ<a name=\"fr-bd-dose-form-INJ\"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style=\"white-space:nowrap\">SOL<a name=\"fr-bd-dose-form-SOL\"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style=\"white-space:nowrap\">CRM<a name=\"fr-bd-dose-form-CRM\"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style=\"white-space:nowrap\">LOT<a name=\"fr-bd-dose-form-LOT\"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div></div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:extension ( [
     fhir:url [
       fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"^^xsd:anyURI ;
       fhir:l <http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm>
     ] ;
     fhir:value [
       a fhir:Integer ;
       fhir:v 1 ;
       fhir:extension ( [
         fhir:url [
           fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom"^^xsd:anyURI ;
           fhir:l <http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom>
         ] ;
         fhir:value [
           a fhir:Canonical ;
           fhir:v "https://fhir.dghs.gov.bd/core/ImplementationGuide/bd.fhir.core"^^xsd:anyURI ;
           fhir:l <https://fhir.dghs.gov.bd/core/ImplementationGuide/bd.fhir.core>
         ]
       ] )
     ]
  ] [
     fhir:url [
       fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"^^xsd:anyURI ;
       fhir:l <http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status>
     ] ;
     fhir:value [
       a fhir:Code ;
       fhir:v "informative" ;
       fhir:extension ( [
         fhir:url [
           fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom"^^xsd:anyURI ;
           fhir:l <http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom>
         ] ;
         fhir:value [
           a fhir:Canonical ;
           fhir:v "https://fhir.dghs.gov.bd/core/ImplementationGuide/bd.fhir.core"^^xsd:anyURI ;
           fhir:l <https://fhir.dghs.gov.bd/core/ImplementationGuide/bd.fhir.core>
         ]
       ] )
     ]
  ] ) ; # 
  fhir:url [
     fhir:v "https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form"^^xsd:anyURI ;
     fhir:l <https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form>
  ] ; # 
  fhir:version [ fhir:v "0.2.4"] ; # 
  fhir:name [ fhir:v "BDMedicationDoseForm"] ; # 
  fhir:title [ fhir:v "Bangladesh Medication Dose Form CodeSystem"] ; # 
  fhir:status [ fhir:v "draft"] ; # 
  fhir:date [ fhir:v "2026-03-06T18:27:26+00:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "Directorate General of Health Services (DGHS), Bangladesh"] ; # 
  fhir:contact ( [
     fhir:telecom ( [
       fhir:system [ fhir:v "url" ] ;
       fhir:value [ fhir:v "http://dghs.gov.bd" ]
     ] )
  ] ) ; # 
  fhir:description [ fhir:v "Medication dose form codes according to CCDS guideline"] ; # 
  fhir:jurisdiction ( [
     fhir:coding ( [
       fhir:system [
         fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ;
         fhir:l <urn:iso:std:iso:3166>
       ] ;
       fhir:code [ fhir:v "050" ]
     ] )
  ] ) ; # 
  fhir:content [ fhir:v "complete"] ; # 
  fhir:count [ fhir:v "10"^^xsd:nonNegativeInteger] ; # 
  fhir:concept ( [
     fhir:code [ fhir:v "TAB" ] ;
     fhir:display [ fhir:v "Tablet" ] ;
     fhir:definition [ fhir:v "Solid oral dosage form, usually uncoated or coated, intended for swallowing." ]
  ] [
     fhir:code [ fhir:v "DTAB" ] ;
     fhir:display [ fhir:v "Dispersible Tablet" ] ;
     fhir:definition [ fhir:v "Tablet designed to be dissolved/dispersed in water before administration." ]
  ] [
     fhir:code [ fhir:v "CAP" ] ;
     fhir:display [ fhir:v "Capsule" ] ;
     fhir:definition [ fhir:v "Solid dosage form with active ingredients enclosed in a gelatin shell." ]
  ] [
     fhir:code [ fhir:v "SYP" ] ;
     fhir:display [ fhir:v "Syrup" ] ;
     fhir:definition [ fhir:v "Liquid oral dosage form containing active substance(s) in solution." ]
  ] [
     fhir:code [ fhir:v "SUSP" ] ;
     fhir:display [ fhir:v "Suspension" ] ;
     fhir:definition [ fhir:v "Liquid oral dosage form with insoluble particles dispersed in a liquid." ]
  ] [
     fhir:code [ fhir:v "PFS" ] ;
     fhir:display [ fhir:v "Powder for Suspension" ] ;
     fhir:definition [ fhir:v "Powder that requires reconstitution into a liquid suspension before use." ]
  ] [
     fhir:code [ fhir:v "INJ" ] ;
     fhir:display [ fhir:v "Injection" ] ;
     fhir:definition [ fhir:v "Sterile solution or suspension intended for parenteral administration." ]
  ] [
     fhir:code [ fhir:v "SOL" ] ;
     fhir:display [ fhir:v "Solution" ] ;
     fhir:definition [ fhir:v "Liquid dosage form where drug is fully dissolved in a solvent." ]
  ] [
     fhir:code [ fhir:v "CRM" ] ;
     fhir:display [ fhir:v "Cream" ] ;
     fhir:definition [ fhir:v "Semi-solid topical dosage form containing the drug in an emulsion base." ]
  ] [
     fhir:code [ fhir:v "LOT" ] ;
     fhir:display [ fhir:v "Lotion" ] ;
     fhir:definition [ fhir:v "Low-viscosity liquid topical dosage form for external application." ]
  ] ) . # 

# -------------------------------------------------------------------------------------

